Response of gut microbiota to serum metabolome changes in intrahepatic cholestasis of pregnant patients
Guohua Li, Shijia Huang, Xiang Li, Xiao-Song Liu, Qiaoling Du
Abstract
BACKGROUND: Intrahepatic cholestasis in pregnancy (ICP) is the most common liver disease during pregnancy, and its exact etiology and course of progression are still poorly understood. AIM: To investigate the link between the gut microbiota and serum metabolome in ICP patients. METHODS: In this study, a total of 30 patients were recruited, including 15 patients with ICP (disease group) and 15 healthy pregnant patients (healthy group). The serum nontarget metabolomes from both groups were determined. Amplification of the 16S rRNA V3-V4 region was performed using fecal samples from the disease and healthy groups. By comparing the differences in the microbiota and metabolite compositions between the two groups, the relationship between the gut microbiota and serum metabolites was also investigated. RESULTS: ). Our results also showed that specific genera were associated with the serum metabolome. CONCLUSION: Our study showed that the serum metabolome was altered in ICP patients compared to healthy controls, with significant differences in the bile, taurine and hypotaurine metabolite pathways. Alterations in the metabolization of these pathways may lead to disturbances in the gut microbiota, which may further affect the course of progression of ICP.